Congenital Central Hypoventilation Syndrome

What It Is, Causes, and More

Author: Ashley Mauldin, MSN, APRN, FNP-BC, CNE
Editor: Alyssa Haag, MD
Editor: Ian Mannarino, MD, MBA
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Jannat Day
Modified: Jan 06, 2025

What is congenital central hypoventilation syndrome?

Congenital central hypoventilation syndrome (CCHS), also known as Ondine’s curse, is a rare neurological condition characterized by alveolar hypoventilation and autonomic nervous system dysregulation. CHHS is a life-threatening condition that causes an oxygen shortage and an accumulation of carbon dioxide in the blood. Usually, patients with CCHS require lifelong ventilatory support 

CCHS affects the autonomic nervous system, which can cause an inability to control breathing, especially during sleep, thereby resulting in an imbalance of oxygen and carbon dioxide in the blood. Usually, when this occurs, the autonomic nervous system will correct by causing the individual to wake up or begin taking deeper breaths; however, in individuals with CCHS, the autonomic nervous system reaction is compromised.  

An infographic detailing the background, causes, risk factors, signs and symptoms, diagnosis, and treatment of congenital central hypoventilation syndrome.

What causes congenital central hypoventilation syndrome?

CCHS is caused by mutations in the PHOX2B gene, which is involved in the development of the nervous system in utero.  Although most cases of CCHS have been found to be spontaneous in nature (i.e., de novo), it is considered a dominant genetic condition, meaning that only one mutated gene needs to be present for the condition to occur. Therefore, both those assigned female and male at birth can be affected equally.  

Mutations in the PHOX2B gene can be due to repeat mutations, also known as polyalanine repeat expansion mutations (PARMS); or a gene mutation on the PHOX2B gene that isn’t repeating, known as non-polyalanine repeat expansion mutations (NPARMS). Regardless of the type of mutation, there is impaired function of the PHOX2B gene.  

What are the signs and symptoms of congenital central hypoventilation syndrome?

Signs and symptoms of CCHS usually include reduced or shallow breathing related to the individual's inability to control their breathing. This impaired breathing will usually be seen during both REM and non-REM sleep but can also be present while awake. An individual may also experience blue discoloration in the skin and lipswhich occurs when the oxygen levels in the blood are low.  

Other signs and symptoms can include impairment in the cardiovascular system, including temperature regulation issues, and alterations in heart rate and blood pressure, including prolonged sinus pauses and asystole in severe cases. Other symptoms suggesting autonomic dysregulation include seizures and altered pupillary reaction to light. Additionally, some children with CCHS can have abnormal development of neural-crest derived structures, leading to decreased gastrointestinal motility; gastrointestinal reflux; and Hirschsprung disease, which is a condition where nerve cells are not present in the large intestine thereby resulting in the inability to pass stool. Individuals may also have tumors of neural crest origin, such as neuroblastoma, ganglioneuroma, or ganglioneuroblastoma.

How is congenital central hypoventilation syndrome diagnosed?

CCHS is diagnosed through a history and physical examination looking for the hallmark clinical features and confirmed through genetic testing to identify the mutated PHOX2B gene. CCHS is most commonly present at birth, but it can also be diagnosed during childhood or adulthood.  

How is congenital central hypoventilation syndrome treated?

Treatment of CCHS is usually aimed at ensuring adequate ventilation, which includes mechanical ventilation with supplemental oxygen. A phrenic pacemaker can also be used to stimulate the phrenic nerve to contract the diaphragm and generate a breath. Those with CCHS need continuous monitoring of their oxygen saturation and carbon dioxide levels. Individuals should be assessed every six months for the first three years, then annually thereafter in a pediatric respiratory physiology laboratory. A child with CCHS who has cardiac involvement may need electrocardiography, echocardiography, Holter monitoring, implantable loop recorders, or even a cardiac pacemaker placement to monitor and treat changes in their cardiac rhythm. 

Management of CCHS usually requires a multidisciplinary approach and includes primary caregivers, pulmonologists, endocrinologists, gastroenterologists, ophthalmologists, oncologists, neurologists, neurodevelopmental psychologists, CCHS specialists, and social workers. Individuals or caretakers should be instructed to avoid swimming and breath-holding, alcohol, recreational drugs, and sedatives that could induce respiratory depression. Afflicted individuals and family members should also receive genetic counseling to understand how the condition could affect future pregnancies. 

What are the most important facts to know about congenital central hypoventilation syndrome?

Congenital central hypoventilation syndrome (CCHS), also known as Ondine’s curse, is a rare, life-threatening neurological condition characterized by alveolar hypoventilation, an oxygen shortage, and an accumulation of carbon dioxide in the blood. CCHS is caused by mutations in the PHOX2B gene, which is involved in the nervous system development in utero. Signs and symptoms of CCHS usually include reduced or shallow breathing, usually observed during both REM and non-REM sleep and also observed while awake. CCHS is diagnosed through a history and physical examination looking for the hallmark clinical features as well as through genetic testing to identify the mutated PHOX2B gene. Treatment of CCHS is usually aimed at ensuring adequate ventilation, and this includes mechanical ventilation with supplemental oxygen using oxygen masks or tracheostomies. A phrenic pacemaker can also be used to stimulate the phrenic nerve, thereby causing the diagram to contract and generate a breath 

References


Cielo C, Marcus CL. Central hypoventilation syndromes. Sleep Med Clin. 2014;9(1):105-118. doi:10.1016/j.jsmc.2013.10.005 


Congenital central hypoventilation syndrome. MedlinePlus Genetics. https://medlineplus.gov/genetics/condition/congenital-central-hypoventilation-syndrome/ 


Shimokaze T, Sasaki A, Meguro T, et al. Genotype-phenotype relationship in Japanese patients with congenital central hypoventilation syndrome. J Hum Genet. 2015;60(9):473-477. doi:10.1038/jhg.2015.65 


Sivan Y, Zhou A, Jennings LJ, et al. Congenital central hypoventilation syndrome: Severe disease caused by co-occurrence of two PHOX2B variants inherited separately from asymptomatic family members. Am J Med Genet A. 2019;179(3):503-506. doi:10.1002/ajmg.a.61047 


Trang, H., Samuels, M., Ceccherini, I. et al. Guidelines for diagnosis and management of congenital central hypoventilation syndrome. Orphanet J Rare Dis. 2020;15(252). doi:10.1186/s13023-020-01460-2 


Weese-Mayer DE, Rand CM, Khaytin I, et al. Congenital Central Hypoventilation Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. https://www.ncbi.nlm.nih.gov/books/NBK1427/